Autoantibodies against oxidized low-density lipoprotein (LDL) and carotid atherosclerosis in patients with rheumatoid arthritis
- PMID: 16095116
Autoantibodies against oxidized low-density lipoprotein (LDL) and carotid atherosclerosis in patients with rheumatoid arthritis
Abstract
Objectives: To examine the relationship between autoantibodies against oxidized low-density lipoprotein (oxLDL-Abs) and the progression of carotid atherosclerosis in patients with rheumatoid arthritis (RA).
Methods: Fifty RA patients without evidence of risk factors for atherosclerosis (RA group) and 30 healthy volunteers (normal group) were investigated. The mean intima-media thickness of the common carotid artery (mean CCA-IMT) was measured by high-resolution B-mode ultrasonography. The titer of IgG oxLDL-Abs was measured by enzyme-linked immunosorbent assay. The relationships among mean CCA-IMT, IgG oxLDL-Ab titer and patient factors such as body mass index, systolic blood pressure, diastolic blood pressure, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and serum lipid levels were examined.
Results: Mean CCA-IMT, CRP, ESR and titer of IgG oxLDL-Abs were significantly higher in the RA group than in the normal group. Although mean CCA-IMT showed a positive correlation only with age in multivariate analysis, IgG oxLDL-Ab titers in the RA group were positively associated with mean CCA-IMT and independently with age and sex by multiple regression analysis.
Conclusions: IgG oxLDL-Abs appear to be associated with the degree of carotid atherosclerosis in patients with RA, and are independent of traditional risk factors for atherosclerotic diseases. These results suggest a possible link between autoimmune mechanisms and accelerated atherosclerosis in RA.
Similar articles
-
Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.J Rheumatol. 2008 Aug;35(8):1495-9. Epub 2008 Jun 15. J Rheumatol. 2008. PMID: 18597411
-
Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis.Joint Bone Spine. 2008 Jul;75(4):416-21. doi: 10.1016/j.jbspin.2008.01.022. Epub 2008 May 23. Joint Bone Spine. 2008. PMID: 18457983
-
Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.Cardiology. 2008;110(4):252-9. doi: 10.1159/000112409. Epub 2007 Dec 12. Cardiology. 2008. PMID: 18073481
-
Oxidation of LDL and its clinical implication.Autoimmun Rev. 2008 Jul;7(7):558-66. doi: 10.1016/j.autrev.2008.04.018. Epub 2008 May 12. Autoimmun Rev. 2008. PMID: 18625445 Review.
-
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders.Autoimmun Rev. 2018 Apr;17(4):366-375. doi: 10.1016/j.autrev.2017.11.028. Epub 2018 Feb 7. Autoimmun Rev. 2018. PMID: 29425936 Review.
Cited by
-
Atherosclerosis and rheumatoid arthritis: more than a simple association.Mediators Inflamm. 2012;2012:147354. doi: 10.1155/2012/147354. Epub 2012 Sep 13. Mediators Inflamm. 2012. PMID: 23024462 Free PMC article.
-
Increased carotid intima-media thickness in rheumatoid arthritis: an update meta-analysis.Clin Rheumatol. 2016 Feb;35(2):315-23. doi: 10.1007/s10067-015-3130-8. Epub 2015 Nov 27. Clin Rheumatol. 2016. PMID: 26614535
-
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside.Signal Transduct Target Ther. 2024 Jan 8;9(1):13. doi: 10.1038/s41392-023-01690-3. Signal Transduct Target Ther. 2024. PMID: 38185721 Free PMC article. Review.
-
Oxidized LDL: diversity, patterns of recognition, and pathophysiology.Antioxid Redox Signal. 2010 Jul 1;13(1):39-75. doi: 10.1089/ars.2009.2733. Antioxid Redox Signal. 2010. PMID: 19888833 Free PMC article. Review.
-
Novel risk factors for cardiovascular disease in rheumatoid arthritis.Immunol Res. 2013 Jul;56(2-3):267-86. doi: 10.1007/s12026-013-8398-7. Immunol Res. 2013. PMID: 23584985
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous